Personalized sleep apnea treatment on the horizon?
NCT ID NCT04875364
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates why people develop obstructive sleep apnea (OSA) and whether the underlying cause affects how they respond to different treatments. Researchers will test three approaches—CPAP, a sleep medication (eszopiclone), and supplemental oxygen—in adults with OSA. The goal is to see if matching treatment to the specific cause of OSA improves outcomes like alertness and blood vessel health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Eszopiclone, Supplemental Oxygen, Continuous Positive Airway Pressure (CPAP)
What this could lead to
If successful, this could lead to personalized treatments for sleep apnea based on an individual's underlying cause, improving effectiveness and reducing side effects.
What could go wrong
This is a mid-stage study with a moderate number of participants, so results may not apply to everyone. The treatments tested may not work for all types of sleep apnea.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altman Clinical and Translational Research Institute Building
La Jolla, California, 92037, United States